Future Science Group
Browse
0194 Suppl.pptx (41.87 kB)
Download file

Supplementary Figure – Indirect comparisons of brigatinib and alectinib for front-line ALK-positive non-small-cell lung cancer

Download (41.87 kB)
figure
posted on 2022-05-24, 10:23 authored by Figshare Future Science GroupFigshare Future Science Group, Karen L Reckamp, Huamao M Lin, Holly Cranmer, Yanyu Wu, Pingkuan Zhang, Laura J Walton, Stephen Kay, Allie Cichewicz, Binod Neupane, Kyle Fahrbach, Sanjay Popat, D Ross Camidge

 Figure A 1. PRISMA flow diagram 

History

Usage metrics

    Future OncologyFuture Oncology

    Categories

    Keywords

    alectinibALK inhibitorbrigatinibBucher ITCmatching-adjusted indirect comparisonNSCLCprogression-free survivalsystematic literature review

    Licence

    CC BY-NC-ND 4.0

    Exports